AIM ImmunoTech Inc. (AIM UA) · 10+ Years of Financial statements

Income Statement	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cost of Revenue	1	1	1	2	1	1	2	1	1	1	1	1	1	- -	- -
+ Cost of Goods & Services	1	1	1	2	1	1	2	1	1	1	1	1	1	- -	- -
Gross Profit	- -	-1	-1	-2	-1	-1	-1	-1	-1	-1	-1	-1	-1	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Operating Expenses	13	15	13	19	16	18	15	13	11	11	12	14	16	20	32
+ Selling, General & Admin	6	8	7	9	8	9	7	8	7	6	7	9	9	13	21
+ Research & Development	7	8	7	10	8	9	8	5	4	5	5	6	8	7	11
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-13	-16	-14	-20	-17	-19	-17	-14	-11	-11	-12	-15	-17	-20	-32
- Non-Operating (Income) Loss	-13	-3	-5	-3	-1	-2	-1	-6	-3	-2	-3	-1	2	- -	-3
+ Interest Expense, Net	- -	-2	-1	-2	-1	-1	- -	- -	- -	- -	- -	- -	- -	-1	-1
+ Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	1	- -	- -	- -
- Interest Income	- -	2	1	2	1	1	- -	- -	- -	- -	- -	- -	- -	1	1
+ Other Non-Op (Income) Loss	-13	-1	-5	-1	- -	-1	-1	-6	-3	-2	-3	-1	2	- -	-2
Pretax Income	- -	-13	-9	-17	-16	-17	-15	-8	-8	-10	-9	-14	-19	-19	-29
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-7	-13	-9	-17	-16	-17	-15	-8	-8	-10	-9	-14	-19	-19	-29
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-7	-13	-9	-17	-16	-17	-15	-8	-8	-10	-9	-14	-19	-19	-29
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-7	-13	-9	-17	-16	-17	-15	-8	-8	-10	-9	-14	-19	-19	-29
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-7	-13	-9	-17	-16	-17	-15	-8	-8	-10	-9	-14	-19	-19	-29
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	1	4	32	47	48	49
Basic EPS, GAAP	-34.69	-51.72	-35.21	-65	-51.18	-48.88	-34.07	-15.12	-12.67	-9.79	-2.58	-0.45	-0.4	-0.4	-0.6
Basic EPS from Cont Ops	-34.69	-51.72	-35.21	-65	-51.18	-48.88	-34.07	-15.12	-12.67	-9.79	-2.58	-0.45	-0.4	-0.4	-0.6
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	1	4	32	47	48	49
Diluted EPS, GAAP	-34.69	-51.72	-35.21	-65	-51.18	-48.88	-34.07	-15.12	-12.67	-9.79	-2.58	-0.45	-0.4	-0.4	-0.6
Diluted EPS from Cont Ops	-34.69	-51.72	-35.21	-65	-51.18	-48.88	-34.07	-15.12	-12.67	-9.79	-2.58	-0.45	-0.4	-0.4	-0.6
EBITDA	-13	-16	-14	-20	-16	-18	-15	-13	-10	-11	-12	-14	-16	-20	-32
EBITDA Margin (%)	-11,282.88	-11,560.74	-8,487.58	-9,228.64	-10,866.67	-9,115.23	-11,624.06	-13,588.04	-2,381.01	-2,893.19	-8,322.14	-8,763.19	-12,062.22	-13,948.23	-15,682.18
EBITA	-13	-16	-14	-20	-17	-19	-17	-14	-11	-11	-12	-15	-17	-20	-32
EBIT	-13	-16	-14	-20	-17	-19	-17	-14	-11	-11	-12	-15	-17	-20	-32
Gross Margin (%)	-426.13	-893.33	-547.83	-833.8	-722.67	-535.03	-1,101.5	-1,104.35	-170.71	-140.87	-537.86	-394.48	-529.63	100	79.21
Operating Margin (%)	-11,949.55	-12,138.52	-8,878.88	-9,549.3	-11,444.67	-9,694.92	-12,518.8	-15,004.35	-2,612.36	-3,132.43	-8,887.86	-9,212.88	-12,636.3	-14,129.79	-15,800
Profit Margin (%)	-6,468.47	-9,730.37	-5,599.38	-8,147.42	-10,816.67	-8,857.87	-11,451.13	-8,154.35	-1,889.93	-2,677.66	-6,717.14	-8,834.36	-14,168.15	-13,790.78	-14,337.62
Sales per Employee	2,523	2,411	2,729	5,757	3,846	5,324	4,433	2,706	16,185	11,121	5,385	7,087	5,870	5,875	7,214
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	1	1	1	1	1	1	1	1	1	1	1	1	1	- -	- -

Balance Sheet	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	58	37	32	45	19	17	11	7	4	4	10	40	50	36	15
+ Cash, Cash Equivalents & STI	58	36	30	44	18	16	9	6	2	2	9	39	48	34	13
+ Cash & Cash Equivalents	58	3	3	2	1	2	2	2	1	- -	1	39	32	27	5
+ ST Investments	- -	33	27	42	17	14	7	3	1	2	7	1	16	7	8
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	2	2	1
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	- -	- -	1
+ Inventories	- -	1	1	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	1	1	- -	- -	1	1	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	1	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	1	- -	-1	- -	- -	-1	-1	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	- -	- -	1	- -	- -	- -	- -	1	1	1	1	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	7	15	12	13	13	13	12	12	11	10	10	24	7	4	5
+ Property, Plant & Equip, Net	5	5	7	12	12	12	11	10	9	8	7	7	4	1	1
+ Property, Plant & Equip	7	8	10	16	16	17	17	16	16	16	16	16	6	3	2
- Accumulated Depreciation	2	3	3	4	4	5	6	7	8	8	9	9	2	2	1
+ LT Investments & Receivables	- -	9	4	- -	- -	- -	- -	- -	- -	- -	- -	15	- -	- -	- -
+ LT Investments	- -	9	4	- -	- -	- -	- -	- -	- -	- -	- -	15	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	2	1	1	1	1	1	1	2	2	2	3	2	3	3	4
+ Total Intangible Assets	1	1	1	1	1	1	1	1	1	1	1	1	2	2	2
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	1	1	1	1	1	1	1	1	1	1	1	1	2	2	2
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	1	- -	- -	- -	- -	- -	- -	2	1	1	2	1	1	1	2
Total Assets	65	52	44	58	32	29	23	19	14	14	21	65	58	40	19
+ Payables & Accruals	3	3	3	3	2	3	2	2	2	1	1	1	1	1	8
+ Accounts Payable	1	1	2	2	1	2	1	1	1	1	- -	- -	- -	- -	6
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	1	1	1	1	1	1	1	1	1	- -	- -	- -	- -	1	2
+ ST Debt	- -	- -	2	7	- -	- -	- -	- -	- -	4	- -	- -	- -	- -	- -
+ ST Borrowings	- -	- -	2	7	- -	- -	- -	- -	- -	4	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	1	2	- -	2	- -	- -	1	1	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	1	2	- -	2	- -	- -	1	1	- -	- -	- -	- -	- -
Total Current Liabilities	3	3	5	13	3	4	2	2	3	5	1	1	1	1	9
+ LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	2	6	2	- -	1	- -
+ LT Borrowings	- -	- -	- -	- -	- -	- -	- -	- -	2	- -	4	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	2	- -	1	- -
+ Other LT Liabilities	4	3	- -	- -	- -	- -	- -	1	1	1	- -	- -	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	4	3	- -	- -	- -	- -	- -	1	1	1	- -	- -	- -	- -	- -
Total Noncurrent Liabilities	4	3	- -	- -	- -	- -	- -	1	3	3	6	2	- -	1	- -
Total Liabilities	6	6	6	13	3	4	2	3	6	9	7	3	1	2	9
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1
+ Share Capital & APIC	263	265	265	289	290	303	313	316	317	324	340	403	417	418	419
+ Common Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	263	265	265	289	290	303	313	316	317	324	340	403	417	418	419
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-205	-218	-227	-244	-260	-278	-293	-301	-309	-319	-328	-342	-361	-381	-410
+ Other Equity	- -	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	59	46	38	45	29	25	20	15	9	5	13	61	57	38	10
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	59	46	38	45	29	25	20	15	9	5	13	61	57	38	10
Total Liabilities & Equity	65	52	44	58	32	29	23	19	14	14	21	65	58	40	19
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	1	1	1	10	42	48	48	49
Capital Leases - Total	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	2	- -	1	1
Net Debt	-58	-3	-1	5	-1	-2	-2	-2	- -	3	3	-38	-32	-27	-5
Net Debt to Equity	-98.94	-6.36	-2.71	10.83	-2.74	-8.62	-10.38	-15.54	4.86	63.94	19.74	-62.44	-56.42	-70.33	-53.15
Tangible Common Equity Ratio	90.18	88.73	86.99	77.06	91.66	84.48	88.91	81.25	58.77	32.95	58.73	93.62	97.25	92.95	42.37
Current Ratio	22.33	12.95	6.27	3.54	7.33	3.72	4.34	2.85	1.29	0.72	9.27	36.58	74.61	26.69	1.68
Cash Conversion Cycle	1,628.97	-117.76	-181.61	-329.49	-734.04	-489	-54.16	1,976.43	-241.13	-164.57	128.27	-106.26	2,139.61	- -	-28,120.32
Number of Employees	44	56	59	37	39	37	30	34	27	33	26	23	23	24	28

Cash Flow Statement	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	-7	-13	-9	-17	-16	-17	-15	-8	-8	-10	-9	-14	-19	-19	-29
+ Depreciation & Amortization	1	1	1	1	1	1	1	1	1	1	1	1	1	- -	- -
+ Non-Cash Items	-5	- -	-2	1	1	- -	1	-1	-2	- -	- -	3	3	2	- -
+ Stock-Based Compensation	1	1	- -	- -	- -	- -	- -	- -	1	1	1	1	2	1	- -
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	1	2	- -	- -
+ Other Non-Cash Adj	-6	-1	-2	1	- -	- -	- -	-2	-2	-1	-1	1	2	1	- -
+ Chg in Non-Cash Work Cap	2	1	- -	2	-3	2	-3	- -	1	-2	-1	1	1	1	7
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1	- -	- -	-1	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	-1	- -	- -	-1	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	- -	- -
+ Inc (Dec) in Accts Payable	2	- -	1	3	-3	2	-1	- -	1	-1	-1	- -	- -	1	7
+ Inc (Dec) in Other	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-9	-12	-10	-13	-17	-14	-16	-7	-8	-11	-9	-10	-14	-16	-21
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	4	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	4	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	-1	-1	-2	-6	-1	-1	- -	- -	- -	- -	- -	-1	-1	- -	- -
+ Acq of Fixed Prod Assets	- -	-1	-2	-6	-1	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1	-1	- -	- -
+ Net Change in LT Investment	- -	-42	11	-10	24	3	7	3	3	-1	-6	-9	- -	7	- -
+ Dec in LT Investment	- -	7	21	23	24	3	7	3	3	- -	- -	10	22	10	1
+ Inc in LT Investment	- -	-50	-10	-33	- -	- -	- -	- -	- -	-1	-6	-19	-23	-3	-2
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	-1	-44	9	-16	22	3	6	3	3	- -	-6	-9	-1	11	-1
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	11	-7	- -	- -	- -	2	5	1	-5	-5	- -	- -
+ Cash From Debt	- -	- -	- -	11	- -	- -	- -	- -	2	7	4	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	-7	- -	- -	- -	- -	-2	-3	-5	-5	- -	- -
+ Cash (Repurchase) of Equity	56	- -	- -	23	- -	13	10	5	2	5	15	61	13	- -	- -
+ Increase in Capital Stock	56	- -	- -	23	- -	13	10	5	2	5	15	61	13	- -	- -
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	6	- -	2	-5	- -	- -	- -	- -	- -	-1	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	62	- -	2	28	-7	13	10	5	4	9	16	57	8	- -	- -
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	52	-55	- -	-1	-1	1	- -	- -	-1	-1	1	37	-6	-5	-22
EBITDA	-13	-16	-14	-20	-16	-18	-15	-13	-10	-11	-12	-14	-16	-20	-32
EBITDA Margin (%)	-11,282.88	-11,560.74	-8,487.58	-9,228.64	-10,866.67	-9,115.23	-11,624.06	-13,588.04	-2,381.01	-2,893.19	-8,322.14	-8,763.19	-12,062.22	-13,948.23	-15,682.18
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow	-10	-13	-12	-19	-18	-15	-17	-8	-8	-11	-9	-11	-15	-16	-21
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	-10	-13	-12	-8	-25	-14	-16	-8	-6	-5	-7	-15	-19	-12	-21
Free Cash Flow per Basic Share	-47.69	-50.99	-47.39	-71.54	-56.91	-41.25	-37.01	-15.79	-12.29	-10.72	-2.59	-0.34	-0.31	-0.34	-0.44
Price/Free Cash Flow	-7.27	-6.07	-3.35	-5.11	-2.65	-3.2	-1.21	-2.17	-1.2	-0.8	-0.23	-6.03	-3.48	-0.97	-1.05
Cash Flow to Net Income	1.29	0.9	1.12	0.76	1.04	0.8	1.05	0.98	0.96	1.08	0.96	0.72	0.73	0.83	0.73

AIM ImmunoTech Inc.

AIM UA

0.45